StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IPSC

Century Therapeutics, Inc.

IPSC Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$1.98
-0.21 -9.59%

Key statistics

from XBRL data in SEC filings
Market cap
$357M
Revenue (TTM)
$115M
Net income (TTM)
-$108M
EPS (TTM)
$-1.14
P/E ratio
Dividend yield
Free cash flow
-$105M
Cash
$51.0M
Total assets
$327M
Gross margin
52-week range
$0.44 – $3.04

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jun 16, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 12, 2026 8-K Other events Jun 8, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Other events Mar 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Shareholder vote results; Other events Jan 23, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 8, 2026 8-K Director or officer change Dec 29, 2025 8-K Regulation FD disclosure Dec 12, 2025 8-K Director or officer change; Regulation FD disclosure Dec 9, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Delisting notice or listing-rule failure Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Aug 14, 2025 8-K Exit or disposal costs; Director or officer change Jul 7, 2025 8-K Shareholder vote results Jun 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Mar 19, 2025 8-K Delisting notice or listing-rule failure Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Terminated a material agreement Dec 13, 2024 8-K Results of operations (earnings release); Other events Nov 5, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Director or officer change Sep 26, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Other events Jul 8, 2024 8-K/A FORM 8-K/A Jun 26, 2024 8-K Shareholder vote results Jun 24, 2024 8-K Other events Jun 3, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Apr 11, 2024